Results 191 to 199 of about 1,620 (199)

Molecular masquerading of rare EGFR L858M/L861R mutations as common L858R/L861Q mutations by PNA clamping assay

Pathology, 2017
Sug Lee, Ji Hyung Hong, Yeun-Jun Chung
exaly  

Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR

Journal of Thoracic Oncology, 2013
Dara Aisner, Robert Doebele
exaly  

Osimertinib in uncommon EGFR exon 21 L861R and EGFR exon 18 deletion-insertion mutant non-small cell lung cancer—case report

Translational Lung Cancer Research
Surein Arulananda
exaly  

Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275

Journal of the National Cancer Institute, 1992
exaly  

Lung adenocarcinoma with EGFR L858R-K860I and L858R-L861F doublet mutations from which the L858R mutation is undetectable through the cobas EGFR mutation test v2

Pathology Research and Practice
Wei-Yu Liao, Min-Shu Hsieh, Yen-Lin Huang   +2 more
exaly  

[19. Jan .L869]

1870
exaly  

Case report: Favorable efficacy of combined afatinib and anlotinib treatment in a lung adenocarcinoma patient harboring uncommon EGFR L858M/L861R mutations

Frontiers in Pharmacology
Yueming He, He Rongqi
exaly  

[142] IAph 12.719 - [145] ITra1l86

2014
exaly  

L868 (L8) To the Rev. John Preston Wright

1974
exaly